Display options
Share it on

Open AIDS J. 2009 Jan 23;3:4-7. doi: 10.2174/1874613600903010004.

Cross-clade recognition of HIV-1 CAp24 by CD4+ T cells in HIV-1-infected individuals in Burkina Faso and Germany.

The open AIDS journal

Thomas Böhler, Vanessa Mrosek, Kerstin Müller, Paul Schnitzler, Martin Hartmann, Thierry Ouedraogo, Boubacar Coulibaly, Ali Sié, Vanda Bartonova, Denis M Tebit, Hans-Georg Kräusslich

Affiliations

  1. Department of Virology, University of Heidelberg, Im Neuenheimer Feld 324, D-69120 Heidelberg, Germany. [email protected]

PMID: 19554213 PMCID: PMC2701271 DOI: 10.2174/1874613600903010004

Abstract

The presence of antigen-specific cellular immune responses may be an indicator of long-term asymptomatic HIV-1-disease. The detection of cellular immune responses to infection with different subtypes of HIV-1 may be hampered by genetic differences of immunodominant antigens such as the capsid protein CAp24. In Nouna, Burkina Faso, HIV-1 circulating recombinant forms CRF02_AG and CRF06_cpx are the 2 major strains detectable in HIV-1-infected individuals, while subtype B strains prevail in Europe and North America. Amino acid sequences of CAp24 were assessed in blood samples from 10 HIV-1-infected patients in Nouna, Burkina Faso. Production of interferon-gamma (IFN-gamma) in peripheral blood CD4(+) lymphocytes in response to recombinant HIV-1 proteins derived from clade B (including CAp24(NL4-3)) was measured using a modified flow-cytometry-based whole blood short term activation assay (FASTimmune, BDBiosciences). IFN-gamma production following stimulation with a whole length CAp24 protein derived from clade B (CAp24(NL4-3)) was additionally quantified in comparison to a CAp24 protein derived from CRF02_AG (CAp24(BD6-15)) in 16 HIV-1-infected patients in Heidelberg, Germany. Amino acid sequence identity of CAp24 obtained from patients in Nouna ranged between 86 and 89% when compared to the clade B CAp24(NL4-3) consensus sequence, between 90 and 95% when compared to the circulating recombinant form CRF06_CPX consensus sequence, and between 92 and 96% when compared to the CAp24(BD6-15) consensus sequence. Significant numbers of HIV-1-specific CD4(+) lymphocytes producing IFN-gamma were detected in 4 of 10 HIV-1-infected patients. In 7 of 16 patients in Heidelberg, recombinant CAp24(BD6-15) stimulated IFN-gamma-production in CD4(+) lymphocytes to a similar extent as the clade B-derived CAp24(NL4-3). Thus, antigen-specific CD4(+) lymphocytes from both West African and European patients infected with different strains of HIV-1 show relevant cross-clade recognition of HIV-1 CAp24 in a flow-cytometry-based whole blood short term activation assay.

References

  1. Nat Med. 2005 Oct;11(10):1118-24 - PubMed
  2. AIDS Res Hum Retroviruses. 2004 Jul;20(7):763-71 - PubMed
  3. AIDS. 2006 Feb 14;20(3):353-60 - PubMed
  4. J Virol. 2005 Sep;79(17):11247-58 - PubMed
  5. Virology. 2003 Sep 1;313(2):645-52 - PubMed
  6. AIDS Res Hum Retroviruses. 1990 Oct;6(10):1169-75 - PubMed
  7. J Acquir Immune Defic Syndr. 2006 Oct 1;43(2):144-52 - PubMed
  8. J Virol. 2007 Nov;81(21):12071-6 - PubMed
  9. AIDS Res Hum Retroviruses. 2004 Mar;20(3):315-25 - PubMed
  10. J Virol. 2002 Sep;76(17):8757-68 - PubMed
  11. BMC Immunol. 2005 Jun 24;6:13 - PubMed

Publication Types